Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Tor1 Activators

The class of chemicals known as Tor1 Activators consists of compounds that primarily act on the PI3K/Akt pathway, the cAMP/PKA pathway, or the intracellular level of essential amino acids or glucose, leading to the indirect activation of Tor1. Tor1 is part of the TORC1 complex that is regulated by these pathways. The first group of activators form part of the PI3K/Akt pathway, which leads to the inhibition of the TSC1/2 complex, a negative regulator of the TOR pathway. This removes the inhibitory effect on Tor1, leading to its activation. Activators of this class also interact with the TOR pathway through the Rag GTPases and AMPK, respectively. They activate the TOR pathway when intracellular levels of amino acids are high, while glucose does so by increasing the cellular energy level, which is sensed directly by AMPK.

Tor1 Activators enhance the cAMP/PKA pathway, causing the PKA-dependent inhibition of the TSC1/2 complex, leading to the activation of Tor1. They also act on acetyltransferase EP300 and Sirt. A small group of activators in this class exert their effects on Tor1 through more unique mechanisms. They inhibit acetyltransferase EP300, leading to the deacetylation of TSC2, a component of the TSC1/2 complex, which negatively regulates the TOR pathway, including Tor1. Laslty, activators of this class also inhibit Sirt1, a positive regulator of TSC2, thus activating the mTOR pathway and Tor1.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Insulin

11061-68-0sc-29062
sc-29062A
sc-29062B
100 mg
1 g
10 g
$156.00
$1248.00
$12508.00
82
(1)

Insulin can activate the PI3K/Akt pathway, which in turn can stimulate the TORC1 complex that includes Tor1. This activation occurs through the inhibition of TSC1/2, a negative regulator of Tor1.

L-Leucine

61-90-5sc-364173
sc-364173A
25 g
100 g
$21.00
$62.00
(0)

Leucine is an essential amino acid that activates the mTOR pathway, including Tor1, through the Rag GTPases, which are directly sensitive to the intracellular level of amino acids.

D(+)Glucose, Anhydrous

50-99-7sc-211203
sc-211203B
sc-211203A
250 g
5 kg
1 kg
$38.00
$198.00
$65.00
5
(1)

Glucose stimulates the TOR pathway, including Tor1, by increasing the cellular energy level, which is sensed directly by AMPK, a negative regulator of the TOR pathway.

Lysophosphatidic Acid

325465-93-8sc-201053
sc-201053A
5 mg
25 mg
$98.00
$341.00
50
(3)

LPA is a bioactive phospholipid that activates the mTOR pathway, including Tor1, through its action on the PI3K/Akt pathway.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates the mTOR pathway, including Tor1, through its action on protein kinase C (PKC), which can stimulate the PI3K/Akt pathway.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin activates adenylyl cyclase, causing an increase in cAMP levels, which can activate the mTOR pathway, including Tor1, through the PKA-dependent inhibition of TSC1/2.

Spermidine

124-20-9sc-215900
sc-215900B
sc-215900A
1 g
25 g
5 g
$57.00
$607.00
$176.00
(2)

Spermidine can inhibit acetyltransferase EP300, leading to the deacetylation of TSC2, a component of the TSC1/2 complex, which negatively regulates the mTOR pathway including Tor1.

Angiotensin II, Human

4474-91-3sc-363643
sc-363643A
sc-363643B
sc-363643C
1 mg
5 mg
25 mg
100 mg
$51.00
$100.00
$310.00
$690.00
3
(1)

Angiotensin II can activate the mTOR pathway including Tor1, through its action on the PI3K/Akt pathway.

Nicotinamide

98-92-0sc-208096
sc-208096A
sc-208096B
sc-208096C
100 g
250 g
1 kg
5 kg
$44.00
$66.00
$204.00
$831.00
6
(1)

Nicotinamide can inhibit Sirt1, a positive regulator of TSC2, leading to the activation of the mTOR pathway including Tor1.

PACAP(6-38)

137061-48-4sc-391136
sc-391136A
500 µg
1 mg
$540.00
$932.00
(0)

PACAP can activate the mTOR pathway including Tor1, through its action on the cAMP/PKA pathway, leading to the inhibition of TSC1/2.